Alpha Tau Medical Stock Analysis

Alpha Stock Analysis Notes

About 33.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.54. Alpha Tau Medical had not issued any dividends in recent years. Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of solid cancer In Israel and the United States. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel. Alpha Tau is traded on NASDAQ Exchange in the United States. To learn more about Alpha Tau Medical call Uzi Sofer at 972 3 577 4115 or check out https://www.alphatau.com.

Alpha Tau Medical Investment Alerts

Alpha Largest EPS Surprises

View All Earnings Estimates

Alpha Tau Environmental, Social, and Governance (ESG) Scores

Alpha Stock Institutional Investors

Note, although Alpha Tau's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Alpha Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 648.01 M.

Alpha Profitablity

Management Efficiency

Alpha Tau Medical has return on total asset (ROA) of (0.2556) % which means that it has lost $0.2556 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5438) %, meaning that it created substantial loss on money invested by shareholders. Alpha Tau's management efficiency ratios could be used to measure how well Alpha Tau manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.44 in 2026. Return On Capital Employed is likely to gain to -0.4 in 2026. At this time, Alpha Tau's Net Tangible Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 637.5 K in 2026, whereas Non Current Assets Total are likely to drop slightly above 13.6 M in 2026.

Technical Drivers

As of the 5th of February, Alpha Tau shows the Risk Adjusted Performance of 0.1585, downside deviation of 4.45, and Mean Deviation of 3.98. Alpha Tau Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Alpha Tau Medical standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Alpha Tau Medical is priced correctly, providing market reflects its regular price of 7.6 per share. Given that Alpha Tau has jensen alpha of 0.8944, we suggest you to validate Alpha Tau Medical's prevailing market performance to make sure the company can sustain itself at a future point.

Alpha Tau Medical Price Movement Analysis

Alpha Tau Outstanding Bonds

Alpha Tau Predictive Daily Indicators

Alpha Tau Corporate Filings

Alpha Tau Forecast Models

Alpha Tau's time-series forecasting models are one of many Alpha Tau's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alpha Tau's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Alpha Tau Bond Ratings

Alpha Tau Medical financial ratings play a critical role in determining how much Alpha Tau have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Alpha Tau's borrowing costs.

Alpha Tau Medical Debt to Cash Allocation

Alpha Tau Medical currently holds 12.54 M in liabilities. Alpha Tau Medical has a current ratio of 41.14, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Alpha Tau's use of debt, we should always consider it together with its cash and equity.

Alpha Tau Total Assets Over Time

Alpha Tau Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Alpha Tau uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Alpha Tau Debt Ratio

16.0

It appears most of the Alpha Tau's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Alpha Tau's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Alpha Tau, which in turn will lower the firm's financial flexibility.

Alpha Tau Corporate Bonds Issued

Alpha Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Alpha Tau prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alpha shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Alpha Tau. By using and applying Alpha Stock analysis, traders can create a robust methodology for identifying Alpha entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Alpha analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Alpha analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Alpha Tau Medical stock analysis indicators help investors evaluate how Alpha Tau stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Alpha Tau shares will generate the highest return on investment. By understating and applying Alpha Tau stock analysis, traders can identify Alpha Tau position entry and exit signals to maximize returns.

When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.